TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
MAZE

Maze Therapeutics, Inc.

Healthcare · Biotechnology · —

23.40$ -2.0% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Balance Sheet

Maze Therapeutics, Inc. (MAZE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 397 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MAZE
Line item 2022 2023 2024 2025
150 72 241 397
106 34 202 350
100 29 197 189
100 29 197 342
1.5
49 61 44 42
21 16 21 23
4.3 4.5 4.6 4.8
1.6 2.0 1.9 1.8
20
101 10 197 355
-295 -396 -358 -490
44 44 44 43

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?